| Literature DB >> 31052298 |
Fedia Souilem1,2, Maria Inês Dias3, Lillian Barros4, Ricardo C Calhelha5, Maria José Alves6, Fethia Harzallah-Skhiri7, Isabel C F R Ferreira8.
Abstract
The present work aimed to characterize leaves, stems, and flowers of Carissa macrocarpa (Eckl.) A.DC., by performing an analysis of the phenolic compounds by HPLC-DAD/ESI-MS, correlating them with bioactive properties, such as antioxidant, anti-inflammatory, cytotoxic, and antimicrobial activities. Thirty polyphenols were identified in the hydroethanolic extract, including phenolic acids, flavan-3-ols, and flavonol glycosides derivatives (which presented the highest number of identified compounds). However, flavan-3-ols showed the highest concentration in stems (mainly owing to the presence of dimers, trimmers, and tetramers of type B (epi)catechin). Leaves were distinguished by their high antioxidant and anti-inflammatory activities, as well as their bactericidal effect against E. coli, while stems presented a higher cytotoxic activity and bactericidal effect against Gram-positive bacteria. Moreover, a high correlation between the studied bioactivities and the presence of phenolic compounds was also verified. The obtained results bring added value to the studied plant species.Entities:
Keywords: Carissa macrocarpa; Pearson’s correlation; bioactivities; phenolic profile; plant aerial parts
Mesh:
Substances:
Year: 2019 PMID: 31052298 PMCID: PMC6539727 DOI: 10.3390/molecules24091696
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, and tentative identification of the phenolic compounds present in the hydroethanolic extracts of C. macrocarpa leaves, stems, and flowers.
| Peak | Rt (min) | λmax (nm) | [M − H]− ( | MS2 ( | Tentative Identification |
|---|---|---|---|---|---|
|
| 4.65 | 324 | 353 | 191(100),179(45),161(15),135(10) | 3- |
|
| 5.16 | 310 | 337 | 191(100),173(3),161(5) | |
|
| 5.21 | 284 | 359 | 239(95),197(100),181(6),153(10),137(5) | Syringic acid hexoside |
|
| 5.34 | 290 | 337 | 191(100),173(5),161(5) | |
|
| 6.31 | 287 | 353 | 191(32),173(100),161(5),135(5) | |
|
| 6.8 | 325 | 353 | 191(75),173(100),161(12),135(5) | |
|
| 7.35 | 281 | 577 | 425(100),289(13) | Type B (epi)catechin dimer |
|
| 8.1 | 325 | 353 | 191(100),179(35),161(5),135(5) | 5- |
|
| 9.01 | 280 | 577 | 425(100),289(19) | Type B (epi)catechin dimer |
|
| 9.45 | 266,347 | 755 | 593(20),285(100) | Kaempherol- |
|
| 10.26 | 280 | 865 | 451(14),425(16),407(12),289(11) | Type B (epi)catechin trimer |
|
| 11.47 | 280 | 1153 | 865(78),577(35),575(43),289(5) | Type B (epi)catechintetramer |
|
| 10.77 | 284 | 337 | 191(100),173(5),161(5) | |
|
| 11.49 | 280 | 1153 | 865(82),577(24),575(36),289(5) | Type B (epi)catechin tetramer |
|
| 12.15 | 310 | 337 | 191(100),173(3),161(3) | |
|
| 12.41 | 280 | 865 | 451(15),425(13),407(17),289(7) | Type B (epi)catechin trimer |
|
| 12.9 | 280 | 863 | 711(26),573(61),451(12),411(5),289(22) | Type A (epi)catechin trimer |
|
| 13.1 | 267,347 | 739 | 593(100),285(25) | Kaempferol- |
|
| 13.35 | 280 | 1153 | 865(54),577(23),575(24),289(5) | Type B (epi)catechin tetramer |
|
| 13.96 | 265,352 | 755 | 609(100),301(25) | Quercetin- |
|
| 14.07 | 266,357 | 739 | 593(100),285(25) | Kaempferol- |
|
| 14.7 | 257,352 | 609 | 301(100) | Quercetin- |
|
| 15.62 | 280,339 | 739 | 285(100) | Kaempferol- |
|
| 15.95 | 271,344 | 575 | 285(100) | Acetylkaempherol- |
|
| 16.09 | 266,357 | 739 | 593(100),285(25) | Kaempferol- |
|
| 16.39 | 257,348 | 739 | 593(100),285(25) | Kaempferol- |
|
| 16.88 | 266,352 | 609 | 301(100) | Quercetin- |
|
| 17.1 | 257,354 | 609 | 301(100) | Quercetin-3- |
|
| 19.17 | 266,346 | 593 | 285(100) | Kaempherol- |
|
| 20.32 | 266,346 | 593 | 285(100) | Kaempherol-3- |
* Compounds identified and quantified according to their chromatographic characteristics by comparison to those obtained with standard compounds.
Quantification (mg/g of extract) of the phenolic compounds present in the hydroethanolic extracts of C. macrocarpa leaves, stems, and flowers.
| Peak | Leaves | Stems | Flowers |
|---|---|---|---|
|
| nd | 0.49 ± 0.01 | nd |
|
| 0.25 ± 0.01 | nd | nd |
|
| nd | 0.34 ± 0.01 | nd |
|
| 0.34 ± 0.01 b | nd | 0.6 ± 0.01 a |
|
| 0.26 ± 0.004 c | 0.61 ± 0.02 b | 3.1 ± 0.1 a |
|
| 0.5 ± 0.02 b | 2.28 ± 0.02 a | nd |
|
| 2 ± 0.1 b | 6.4 ± 0.2 a | nd |
|
| nd | nd | 0.17 ± 0.01 |
|
| nd | 2.88 ± 0.01 | nd |
|
| nd | nd | 0.48 ± 0.02 |
|
| 1.9 ± 0.1 b | 6.09 ± 0.02 a | nd |
|
| 2.9 ± 0.1 | nd | nd |
|
| nd | 0.97 ± 0.01 b | 1.21 ± 0.02 a |
|
| nd | 7.3 ± 0.2 | nd |
|
| nd | nd | 0.49 ± 0.02 |
|
| 1.9 ± 0.1 b | 3.7 ± 0.1 a | nd |
|
| 1.57 ± 0.05 b | 4.9 ± 0.2 a | nd |
|
| nd | nd | tr |
|
| 2.2 ± 0.1 b | 3.9 ± 0.1 a | nd |
|
| 1.79 ± 0.03 | 1.03 ± 0.01 | nd |
|
| nd | nd | tr |
|
| nd | nd | tr |
|
| 1.03 ± 0.01 | nd | nd |
|
| 1.1 ± 0.03 | nd | nd |
|
| nd | nd | tr |
|
| nd | nd | 1.6 ± 0.1 |
|
| tr | nd | nd |
|
| 1.86 ± 0.04 b | 2.6 ± 0.1 a | 1.48 ± 0.01 c |
|
| nd | nd | tr |
|
| tr | nd | 1.73 ± 0.03 |
|
| 1.35 ± 0.04 c | 4.68 ± 0.01 b | 5.5 ± 0.1 a |
|
| 12.5 ± 0.2 b | 35.1 ± 0.2 a | nd |
|
| 5.7 ± 0.1 a | 3.6 ± 0.1 c | 5.3 ± 0.1 b |
|
| 19.6 ± 0.3 b | 43.4 ± 0.1 a | 10.8 ± 0.2 c |
tr—traces; nd—not detected. Standard calibration curves: caffeic acid (y = 168823x − 161172, R2 = 0.9939; peaks 1, 5, 6, and 8); catechin (y = 84950x − 23200, R2 = 0.9999; peaks 7, 9, 11, 12, 14, 16, 17, and 19); p-coumaric acid (y = 301950x + 6966.7, R2 = 0.9999; peaks 2, 4, 13, and 15); quercetin-3-O-glucoside (y = 34843x − 160173, R2 = 0.9998; peaks 20, 21, 24, and 25); quercetin-3-O-rutinoside (y = 13343x + 76751, R2 = 0.9998; peaks 10, 18, 22, 23, 26, 27, 28, 29, 30, and 31). TPA—total phenolic acids; TF3O—total flavan-3-ols; TF—total flavonols; TPC—total phenolic compounds.
Figure 1Phenolic profile of the hydroethanolic extract of C. macrocarpa leaves recorded at 280 nm (A) and 370 nm (B) obtained by HPLC-DAD/ESI-MS.
Antioxidant, cytotoxic, anti-inflammatory, and antibacterial activities of hydroethanolic extracts of C. macrocarpa leaves, stems, and flowers, and their correlation with the families of the phenolic compounds identified (mean ± SD).
| Leaves | Stems | Flowers | Correlation Factor | ||||
|---|---|---|---|---|---|---|---|
| TPA | TF3O | TF | TPC | ||||
|
| |||||||
| DPPH scavenging activity | 26 ± 1 b | 281 ± 1 a | 223 ± 6 a | 0.887 | 0.862 | m | |
| Reducing power | 36 ± 1 b | 33 ± 1 a | 279 ± 4 b | 0.940 | 0.995 | ||
| β-carotene bleaching inhibition | 300 ± 1 b | 270 ± 10 b | 1107 ± 47 a | m | 0.781 | 0.719 | m |
| TBARS inhibition | 15.4 ± 0.1 b | 12.1 ± 0.1 c | 92.5 ± 0.1 a | m | 0.794 | 0.718 | m |
|
| |||||||
| MCF-7 (breast carcinoma) | 167 ± 2 a | 70.38 ± 0.03 c | 95.25 ± 0.01 b | 0.862 | 0.846 | m | |
| NCI-H460 (non-small cell lung carcinoma) | 120 ± 1 a | 58.7 ± 0.2 c | 68 ± 1 b | 0.911 | 0.898 | m | |
| HeLa (cervical carcinoma) | 101 ± 1 a | 52.1 ± 0.3 c | 75 ± 1 b | 0.721 | m | m | 0.781 |
| HepG2 (hepatocellular carcinoma) | 152 ± 3 a | 89 ± 1 b | >400 | 0.943 | 0.953 | ||
| PLP2 (non-tumour porcine liver primary cells) | >400 | >400 | >400 | - | - | - | - |
|
| |||||||
| NO production | 179 ± 6 c | 208 ± 9 a | 196 ± 4 b | m | |||
|
| |||||||
|
| |||||||
|
| 5 | 10 | 10 | 0.961 | 0.952 | ||
| 20 | 20 | 20 | - | - | - | - | |
|
| >20 | >20 | >20 | - | - | - | - |
| >20 | >20 | >20 | - | - | - | - | |
|
| 10 | 10 | 20 | 0.720 | 0.772 | 0.774 | |
|
| 20 | 20 | 20 | - | - | - | - |
|
| |||||||
|
| 1.25 | 1.25 | 5 | 0.720 | 0.772 | 0.774 | |
|
| 2.5 | 0.625 | 20 | m | 0.825 | m | m |
| MRSA *,F | 2.5 | 2.5 | 20 | 0.720 | 0.772 | 0.742 | m |
| MSSA F | 5 | 2.5 | 10 | 0.938 | m | 0.852 | |
A Trolox EC50 values: 43.03 ± 1.71 μg/mL (DDPH), 29.62 ± 3.15 μg/mL (reducing power), 2.63 ± 0.14 μg/mL (β-carotene bleaching inhibition), and 3.73 ± 1.9 μg/mL (TBARS inhibition); B Ellipticine GI50 value: 0.91 ± 0.04 μg/mL (MCF-7), 1.03 ± 0.09 μg/mL (NCI-H460), 1.91 ± 0.06 μg/mL (HeLa), 1.1 ± 0.2 μg/mL (HepG2), and 3.2 ± 0.7 μg/mL (PLP2); C Dexamethaxone EC50 value: 16 ± 1 μg/mL. S—susceptible; I—intermediate; R—resistant. This classification was made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST): D Amoxicillin/Clavulanic acid (E. coli ≤ 8/4, S; K. pneumoniae ≤ 8/4, S; K. pneumoniae ESBL ≥ 32, R; M. morganii > 16/8, R); E Amikacin (E. coli ESBL 16, I); F Vancomycin (E. faecalis, MRSA, and MSSA ≤ 2, S); G Ampicillin (L. monocytogenes ≤ 0.2, S). In each row and for the different extraction procedure, different letters mean significant differences (p < 0.05). Data shown on correlation factor only considered the strong and very strong correlations ((0.7–0.9) and > 0.9, respectively); m—moderate correlations ((0.5–0.7); w/n—weak and negligible correlations ((0.3–0.5) and (0–0.3), respectively). MIC—minimum inhibitory concentration.